340B Drug Pricing Program Omnibus Guidance (proposed)
GPTKB entity
Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
proposed federal guidance
|
| gptkbp:alsoKnownAs |
gptkb:Mega_Guidance
|
| gptkbp:appliesTo |
covered entities
drug manufacturers |
| https://www.w3.org/2000/01/rdf-schema#label |
340B Drug Pricing Program Omnibus Guidance (proposed)
|
| gptkbp:issuedBy |
gptkb:Health_Resources_and_Services_Administration
|
| gptkbp:publicationDate |
August 28, 2015
|
| gptkbp:purpose |
clarify requirements for covered entities and manufacturers
|
| gptkbp:regulates |
audits
recertification contract pharmacy arrangements duplicate discounts eligibility requirements patient definition |
| gptkbp:relatedTo |
gptkb:340B_Drug_Pricing_Program
|
| gptkbp:status |
proposed
|
| gptkbp:subjectArea |
gptkb:public_policy
drug pricing |
| gptkbp:withdrawn |
2017
|
| gptkbp:bfsParent |
gptkb:340B_Drug_Pricing_Program
|
| gptkbp:bfsLayer |
6
|